An open-label, single-arm phase II study of everolimus (RAD001) in patients with relapsed/refractory classical Hodgkin lymphoma (HL)

被引：0
作者：
Johnston, P. B.
Lewis, L. T.
Rogerio, J. W.
机构：
[1] Mayo Clin Rochester, Rochester, MN USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps299
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS299
引用
收藏
页数：1
相关论文
共 50 条
[21]   Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma [J].
Tobinai, Kensei ;
Ogura, Michinori ;
Maruyama, Dai ;
Uchida, Toshiki ;
Uike, Naokuni ;
Choi, Ilseung ;
Ishizawa, Kenichi ;
Itoh, Kuniaki ;
Ando, Kiyoshi ;
Taniwaki, Masafumi ;
Shimada, Naomi ;
Kobayashi, Ken .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (04) :563-570
[22]   Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study [J].
Guenther, Andreas ;
Baumann, Philipp ;
Burger, Renate ;
Kellner, Christian ;
Klapper, Wolfram ;
Schmidmaier, Ralf ;
Gramatzki, Martin .
HAEMATOLOGICA, 2015, 100 (04) :544-550
[23]   Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma [J].
Song, Yuqin ;
Guo, Ye ;
Huang, Huiqiang ;
Li, Wei ;
Ke, Xiaoyan ;
Feng, Jifeng ;
Xu, Wei ;
Miao, Harry ;
Kinley, Judith ;
Song, Gregory ;
Dai, Yi ;
Wang, Hui ;
Zhu, Jun .
EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (09) :867-875
[24]   A single arm, open-label multicenter phase II trial of everolimus in patients with relapsed/refractory germ cell cancer(RADIT) [J].
Fenner, Martin H. ;
Dieing, Annetta ;
Oechsle, Karin ;
Hentrich, Marcus ;
Gauler, Thomas Christoph ;
Lorch, Anja ;
Kopp, Hans-Georg ;
Beyer, Joerg ;
Bokemeyer, Carsten ;
Gruenwald, Viktor ;
Honecker, Friedmann .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[25]   A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma [J].
Renner, Christoph ;
Zinzani, Pier Luigi ;
Gressin, Remy ;
Klingbiel, Dirk ;
Dietrich, Pierre-Yves ;
Hitz, Felicitas ;
Bargetzi, Mario ;
Mingrone, Walter ;
Martinelli, Giovanni ;
Trojan, Andreas ;
Bouabdallah, Krimo ;
Lohri, Andreas ;
Gyan, Emmanuel ;
Biaggi, Christine ;
Cogliatti, Sergio ;
Bertoni, Francesco ;
Ghielmini, Michele ;
Brauchli, Peter ;
Ketterer, Nicolas .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (07) :1085-1091
[26]   Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma [J].
Johnston, Patrick B. ;
Pinter-Brown, Lauren C. ;
Warsi, Ghulam ;
White, Kristen ;
Ramchandren, Radhakrishnan .
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2018, 7
[27]   Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 study [J].
Shi YuanKai ;
Hong XiaoNan ;
Yang JianLiang ;
Xu Wei ;
Huang HuiQiang ;
Xiao XiuBin ;
Zhu Jun ;
Zhou DaoBin ;
Han XiaoHong ;
Wu JianQiu ;
Zhang MingZhi ;
Jin Jie ;
Ke XiaoYan ;
Li Wei ;
Wu DePei ;
Yang ShenMiao ;
Du Xin ;
Jia YongQian ;
Liu AiChun ;
Liu DaiHong ;
Shen ZhiXiang ;
Zhang LianSheng ;
James Leonard ;
Hellriegel Edward .
中华医学杂志英文版, 2021, 134 (11) :1299-1309
[28]   Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma [J].
Patrick B. Johnston ;
Lauren C. Pinter-Brown ;
Ghulam Warsi ;
Kristen White ;
Radhakrishnan Ramchandren .
Experimental Hematology & Oncology, 7
[29]   Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 study [J].
Shi, Yuan-Kai ;
Hong, Xiao-Nan ;
Yang, Jian-Liang ;
Xu, Wei ;
Huang, Hui-Qiang ;
Xiao, Xiu-Bin ;
Zhu, Jun ;
Zhou, Dao-Bin ;
Han, Xiao-Hong ;
Wu, Jian-Qiu ;
Zhang, Ming-Zhi ;
Jin, Jie ;
Ke, Xiao-Yan ;
Li, Wei ;
Wu, De-Pei ;
Yang, Shen-Miao ;
Du, Xin ;
Jia, Yong-Qian ;
Liu, Ai-Chun ;
Liu, Dai-Hong ;
Shen, Zhi-Xiang ;
Zhang, Lian-Sheng ;
James, Leonard ;
Hellriegel, Edward .
CHINESE MEDICAL JOURNAL, 2021, 134 (11) :1299-1309
[30]   Efficacy and safety of GLS-010 (zimberelimab) in patients with relapsed or refractory classical Hodgkin lymphoma: A multicenter, single-arm, phase II study [J].
Lin, Ningjing ;
Zhang, Mingzhi ;
Bai, Hai ;
Liu, Hui ;
Cui, Jie ;
Ke, Xiaoyan ;
Zhang, Huilai ;
Liu, Lihong ;
Yan, Dongmei ;
Jiang, Yongsheng ;
Zang, Aimin ;
Qi, Junyuan ;
Wang, Li ;
Liu, Zhuogang ;
Xu, Bing ;
Zhang, Ying ;
Zhang, Zhihui ;
Zhao, Xielan ;
Hu, Chunhong ;
Yang, Shenmiao ;
Zhou, Hui ;
Shi, Jinsheng ;
Shao, Zonghong ;
Xiang, Ying ;
Zhu, Jiman ;
Song, Yuqin ;
Zhu, Jun .
EUROPEAN JOURNAL OF CANCER, 2022, 164 :117-126
12345